Table 3.
Obesity Related Factor | Strength of Evidence * |
---|---|
Reduction in Obesity25,39,41,47 | + + + |
Decrease Risk of Developing Type 2 Diabetes Mellitus17 | + + + |
Remission of Type 2 Diabetes Mellitus19 | + |
Decrease Fasting Glucose39,41 | + + + |
Improve Insulin Sensitivity39,41 | + + + |
Lower Blood Pressure41 | + + + |
Reduction in Atrial Fibrillation Burden23 | + + |
Improve Vascular Function43 | + + + |
Reduction in Components of Metabolic Syndrome41 | + + + |
Decrease Platelet Reactivity44 | + |
Decrease Markers of Systemic Inflammation41 | + + + |
Improve Atherogenic Ratio (Total Cholesterol/HDL-Cholesterol)41 | + + + |
Strength of scientific evidence:
+ Some evidence
+ + Moderate evidence
+ + + Strong evidence